NCT07152613View on ClinicalTrials.gov

Corticosteroids for PJP in Non-HIV Immunocompromised Adults

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Pneumocystis Jiroveci Pneumonia
Interventions
DRUG

Saline (0.9%, sterile, for infusion)

Saline for control

DRUG

Low Dose Corticosteroids

Methylprednisolone 0.5mg/kg ivgtt qd

DRUG

Moderate dose corticosteroids

Methylprednisolone 1.0mg/kg ivgtt qd

All Listed Sponsors
lead

Qingyuan Zhan

OTHER